Business
Biotech Stocks Surge Amid Innovation Boom
Biotechnology stocks are experiencing a surge due to recent clinical successes, mergers and acquisitions, and advancements in drug technologies. Analysts recommend specific ETFs and stocks for investors.
Coverage timeline — 1 article
CNBC
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
2026-10-24 18:56 UTC